Neoadjuvant bevacizumab and chemoradiotherapy in locally advanced rectal cancer: early outcome and technical impact on toxicity
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7819
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Neoadjuvant bevacizumab and chemoradiotherapy in locally advanced rectal cancer: early outcome and technical impact on toxicity ; volume:12 ; number:1 ; day:6 ; month:11 ; year:2014 ; pages:1-9 ; date:12.2014
World journal of surgical oncology ; 12, Heft 1 (6.11.2014), 1-9, 12.2014
- Creator
-
Wang, Chia-Chun
Liang, Jin-Tung
Tsai, Chiao-Ling
Chen, Yu-Hsuan
Lin, Yu-Lin
Shun, Chia-Tung
Cheng, Jason Chia-Hsien
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1477-7819-12-329
- URN
-
urn:nbn:de:101:1-2021082107342559868522
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, Chia-Chun
- Liang, Jin-Tung
- Tsai, Chiao-Ling
- Chen, Yu-Hsuan
- Lin, Yu-Lin
- Shun, Chia-Tung
- Cheng, Jason Chia-Hsien
- SpringerLink (Online service)
Other Objects (12)
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
Long-Term Outcomes of Local Excision Following Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
Computertomography-based prediction of complete response following neoadjuvant chemoradiotherapy of locally advanced rectal cancer
Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer
Mucinous histology is a negative predictor of neoadjuvant chemoradiotherapy for locally advanced rectal adenocarcinoma
Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis : Oxaliplatin in neoadjuvant treatment for rectal cancer
The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer
MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
The potential predictive value of tumor budding for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer
Novel biomarkers to predict treatment response and prognosis in locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy
Timing of additional neoadjuvant chemotherapy in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy and total mesorectal excision
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
Long-Term Outcomes of Local Excision Following Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
Computertomography-based prediction of complete response following neoadjuvant chemoradiotherapy of locally advanced rectal cancer
Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer
Mucinous histology is a negative predictor of neoadjuvant chemoradiotherapy for locally advanced rectal adenocarcinoma
Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis : Oxaliplatin in neoadjuvant treatment for rectal cancer
The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer
MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
The potential predictive value of tumor budding for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer
Novel biomarkers to predict treatment response and prognosis in locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy
Timing of additional neoadjuvant chemotherapy in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy and total mesorectal excision
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
Long-Term Outcomes of Local Excision Following Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
Computertomography-based prediction of complete response following neoadjuvant chemoradiotherapy of locally advanced rectal cancer
Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer
Mucinous histology is a negative predictor of neoadjuvant chemoradiotherapy for locally advanced rectal adenocarcinoma
Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis : Oxaliplatin in neoadjuvant treatment for rectal cancer
The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer
MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
The potential predictive value of tumor budding for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer
Novel biomarkers to predict treatment response and prognosis in locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy